Interim Financial Statements
2017Find out more
Malin Corporation plc (ISE:MLC, “Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut, USA and Cambridge, United Kingdom.
Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.
September 22, 2017Melinta Therapeutics to Participate in Two Upcoming Investor Conferences
September 21, 2017Kymab and Seattle Children’s Research Institute publish impressive results using Kymab’s KY1005 in a model of Acute Graft versus Host Disease (aGVHD) in Science Translational Medicine